Neuren Pharmaceuticals
NEU.AX
#4836
Rank
NZ$3.70 B
Marketcap
NZ$29.20
Share price
-0.09%
Change (1 day)
34.44%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2025: NZ$47.21 Million

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are NZ$43.29 Million. In 2025 the company made an earning of NZ$47.21 Million a decrease over its 2024 earnings that were of NZ$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2025

Annual earnings

Year Earnings Change
2025NZ$47.21 M-77.09%
2024NZ$0.20 B-18.58%
2023NZ$0.25 B111519.63%
2022NZ$0.22 M-102.22%
2021-NZ$10.24 Million-20.06%
2020-NZ$12.81 Million-6.65%
2019-NZ$13.72 Million-449.8%
2018NZ$3.92 M-213.69%
2017-NZ$3.45 Million-80.94%
2016-NZ$18.09 Million-3.07%
2015-NZ$18.67 Million51.42%
2014-NZ$12.33 Million-32.7%
2013-NZ$18.32 Million87.47%
2012-NZ$9.77 Million10.96%
2011-NZ$8.81 Million-4.11%
2010-NZ$9.18 Million21025.61%
2009-NZ$0.05 Million-99.78%
2008-NZ$19.63 Million1.99%
2007-NZ$19.24 Million33.24%
2006-NZ$14.44 Million31.45%
2005-NZ$10.99 Million37.67%
2004-NZ$7.98 Million4.98%
2003-NZ$7.61 Million36.5%
2002-NZ$5.57 Million